Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the 2013 Deutsche Bank BioFEST conference being held December 2-3, 2013 at the Four Seasons Hotel in Boston, MA. On Monday, December 2 at 4:00 PM (ET), Burt Adelman M.D., Chief Medical Officer, and George Migausky, Chief Financial Officer, will participate in a fireside chat to discuss the Company’s key value drivers – the KALBITOR® (ecallantide) business, DX-2930 and the Licensing and Funded Research Program.
Help employers find you! Check out all the jobs and post your resume.
